Does SECUKINUMAB Cause Decreased activity? 71 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Decreased activity have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
71
Reports of Decreased activity with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Decreased activity From SECUKINUMAB?
Of the 71 reports, 10 (14.1%) required hospitalization, and 3 (4.2%) were considered life-threatening.
Is Decreased activity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Decreased activity?
NIRAPARIB (586)
SACUBITRIL\VALSARTAN (570)
RUXOLITINIB (558)
DUPILUMAB (231)
LEVOTHYROXINE (201)
TREPROSTINIL (195)
PREDNISONE (193)
ALBUTEROL (190)
EMTRICITABINE\TENOFOVIR DISOPROXIL (186)
TERIPARATIDE (156)
Which SECUKINUMAB Alternatives Have Lower Decreased activity Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG